1 |
SIGMAR1
| [2] Amyotrophic lateral sclerosis Amyotrophic lateral sclerosis, Pathways of neurodegeneration - multiple diseases | D07945
D07945
|
Fenfluramine
| [4] 140 140, 144, 145, 149 |
2 |
SV2C
| [1] ECM-receptor interaction ECM-receptor interaction | D11842
D11842
|
Padsevonil
| [1] 149 149 |
3 |
GABBR1
| [7] cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, GABAergic synapse, Taste transduction, Estrogen signaling pathway, GnRH secretion, Morphine addiction | D00241
D00241
|
Baclofen
| [8] 2 2, 10, 13, 18, 65, 70, 149, 206 |
4 |
HTR1D
| [4] cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, Serotonergic synapse, Taste transduction | D07945
D07945
|
Fenfluramine
| [4] 140 140, 144, 145, 149 |
5 |
HTR2A
| [5] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels | D07945
D07945
|
Fenfluramine
| [4] 140 140, 144, 145, 149 |
6 |
HTR2C
| [5] Calcium signaling pathway Calcium signaling pathway, Neuroactive ligand-receptor interaction, Gap junction, Serotonergic synapse, Inflammatory mediator regulation of TRP channels | D07945
D07945
|
Fenfluramine
| [4] 140 140, 144, 145, 149 |
7 |
SCN3A
| [1] Taste transduction Taste transduction | D07299
D07299
|
Lacosamide
| [2] 149 149, 298 |
8 |
SCN9A
| [1] Taste transduction Taste transduction | D07299
D07299
|
Lacosamide
| [2] 149 149, 298 |
9 |
SLC6A4
| [2] Synaptic vesicle cycle Synaptic vesicle cycle, Serotonergic synapse | D07945
D07945
|
Fenfluramine
| [4] 140 140, 144, 145, 149 |
10 |
SNAP25
| [2] Synaptic vesicle cycle Synaptic vesicle cycle, Insulin secretion | D00783
D00783
|
Botulinum toxin type A
| [14] 2 2, 5, 6, 7, 13, 15, 17, 36, 47, 51, 70, 113, 149, 226 |
11 |
CACNA1I
| [7] MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome | D07971
D07971
|
Flunarizine
| [1] 149 149 |
12 |
CACNA1H
| [7] MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Cushing syndrome | D07971
D07971
|
Flunarizine
| [1] 149 149 |
13 |
CACNA1G
| [8] MAPK signaling pathway MAPK signaling pathway, Calcium signaling pathway, Circadian entrainment, Aldosterone synthesis and secretion, Cortisol synthesis and secretion, GnRH secretion, Type II diabetes mellitus, Cushing syndrome | D07971
D07971
|
Flunarizine
| [1] 149 149 |
14 |
GABBR2
| [7] cAMP signaling pathway cAMP signaling pathway, Neuroactive ligand-receptor interaction, GABAergic synapse, Taste transduction, Estrogen signaling pathway, GnRH secretion, Morphine addiction | D00241
D00241
|
Baclofen
| [8] 2 2, 10, 13, 18, 65, 70, 149, 206 |
15 |
SV2B
| [1] ECM-receptor interaction ECM-receptor interaction | D11842
D11842
|
Padsevonil
| [1] 149 149 |
16 |
SV2A
| [1] ECM-receptor interaction ECM-receptor interaction | D08879
D08879
|
Brivaracetam
| [2] 149 149, 309 |
17 |
SV2A
| [1] ECM-receptor interaction ECM-receptor interaction | D11842
D11842
|
Padsevonil
| [1] 149 149 |